APPF vs GILD · P/E 43, rev $794.2M vs P/E 18, rev $29.44B
Appfolio Inc (APPF) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Appfolio Inc (APPF) is a software - application company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported APPF revenue for 2024-12-31 was $794.2M. Net income was $204.1M. Revenue was up 28.0% from 2023-12-31 to 2024-12-31. APPF currently screens at market cap $8.38B and trailing P/E 43.3.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
APPF currently screens at market cap $8.38B and trailing P/E 43.3. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the APPF and GILD stock pages for the full models.
Not investment advice.